Importantly, T cell exhaustion is associated with liver disease prior to HCC formation, mediated in part by LSEC, indicating the potential of targeted interventions, such as co-immunotherapy with PD-1 and TIGIT, for those affected by chronic liver disease. Here, TIGIT is linked to hepatocellular carcinoma.